The Current State of Occuplastics in Oncology.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 31, doi. 10.1177/155989771443011
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2014 AND VI 14 AND IP 43
Results: 11
1
2
Differential Diagnosis of Unusual Infectious and Inflammatory Diseases of the Eye.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 26, doi. 10.1177/155989771443010
- By:
- Publication type:
- Article
3
Lessons Learned from Recent Clinical Trials on DR.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 21, doi. 10.1177/155989771443009
- By:
- Publication type:
- Article
4
Management of Strabismus in Ophthalmology.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 18, doi. 10.1177/155989771443008
- By:
- Publication type:
- Article
5
Medical and Surgical Management of Glaucoma.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 14, doi. 10.1177/155989771443007
- By:
- Publication type:
- Article
6
A Selection of Hot Topics in Ophthalmology.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 11, doi. 10.1177/155989771443006
- By:
- Publication type:
- Article
7
Methodological Shortcomings Revealed in Clinical Guidelines for Primary Open-Angle Glaucoma.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 9, doi. 10.1177/155989771443004
- By:
- Publication type:
- Article
8
Ranibizumab 0.5 mg Safe and Effective for Treatment of DME.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 8, doi. 10.1177/155989771443003
- By:
- Publication type:
- Article
9
Open-Label Extension of RIDE and RISE Shows Improved Visual Outcomes Maintained without Ranibizumab Retreatment.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 7, doi. 10.1177/155989771443002
- By:
- Publication type:
- Article
10
Advances in the Management of Retinoblastoma.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 4, doi. 10.1177/155989771443001
- By:
- Publication type:
- Article
11
Intravitreal Aflibercept Has Long-Term Benefits in Treatment of DME.
- Published in:
- MD Conference Express, 2014, v. 14, n. 43, p. 10, doi. 10.1177/155989771443005
- By:
- Publication type:
- Article